Showing results (571-580 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|October 23, 2021
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanismsNaveen Manohar Pai, Vidhyavathi Malyam, Manisha Murugesan, et al.International Clinical Psychopharmacology|February 1, 2022
Social withdrawal and neurocognitive correlates in schizophreniaDomenico De Donatis, Stefano Porcelli, Diana De Ronchi, et al.International Clinical Psychopharmacology|March 31, 2022
Antipsychotic prescription patterns and associated factors among the elderly with psychiatric illnessesShu-Wen Cheng, Chao-Wei Lu, Hung-Yu Chan, et al.International Clinical Psychopharmacology|March 31, 2022
Mirtazapine in schizophrenia - an undeservedly overlooked option?Viacheslav Terevnikov, Grigori JoffeInternational Clinical Psychopharmacology|July 6, 2019
Trends of antidementia drugs use in outpatients with Alzheimer's disease in six major cities of China: 2012-2017Lingyan Yu, Xueying Chen, Zhenwei YuInternational Clinical Psychopharmacology|March 8, 2022
Increased risk of death compared to other antipsychotics in elderly clozapine users in PolandPaweł Zagożdzon, Przemysław WaszakInternational Clinical Psychopharmacology|September 19, 2000
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sampleS H Hamilton, E T Edgell, D A Revicki, et al.International Clinical Psychopharmacology|September 20, 2000
Recognizing the patient with social anxiety disorderJ C BallengerInternational Clinical Psychopharmacology|September 20, 2000
Clinical experience with paroxetine in social anxiety disorderD S BaldwinInternational Clinical Psychopharmacology|March 10, 2001
Dose-dependent olanzapine-associated leukopenia: three case reportsA Kodesh, B Finkel, A G Lerner, et al.Pageof 212